Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents : Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
Softcover reprint of the original 1st ed. 1989
Book Details
Format
Paperback / Softback
Book Series
Developments in Cardiovascular Medicine
ISBN-10
1461288886
ISBN-13
9781461288886
Edition
Softcover reprint of the original 1st ed. 1989
Publisher
Springer-Verlag New York Inc.
Imprint
Springer-Verlag New York Inc.
Country of Manufacture
US
Country of Publication
GB
Publication Date
Oct 10th, 2011
Print length
298 Pages
Product Classification:
Cardiovascular medicine
Ksh 32,400.00
Werezi Extended Catalogue
Delivery in 14 days
Delivery Location
Delivery fee: Select location
Delivery in 14 days
Secure
Quality
Fast
The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.
Get Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents by at the best price and quality guaranteed only at Werezi Africa's largest book ecommerce store. The book was published by Springer-Verlag New York Inc. and it has pages.
